NS-220 is an orally active PPARα agonist with high subtype selectivity, with EC 50 values of 1.9×10 -8 M, 9.6×10 -6 M and >10 -4 M for PPARα , PPAR γ and PPARδ , respectively. NS-220 is used in the research for hyperlipidemia or metabolic disorders in type-2 diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PPAR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.